Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
주식 순위 #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
주가
$0.16328419
시가총액
$204.14K
변동 (1일)
4.35%
변동 (1년)
102.45%
국가
GB
거래 Fusion Antibodies plc (FAB)

카테고리

Fusion Antibodies plc (FAB)의 EPS
September 2025 기준 EPS TTM: $-0.02
Fusion Antibodies plc의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.02입니다. 2024년 말에는 회사의 EPS가 $-0.05였으며, 이는 2023년의 EPS $-0.12와 감소입니다.
Fusion Antibodies plc의 EPS 기록 (2013 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL